Tissue microarray (TMA) is a recipient paraffin block that comprises thousands of separate tissue centers assembled in array fashion to allow multiplex histological analysis. These TMAs allow a quick, cost-effective, high through-put examination of thousands of molecular markers at nucleic acids or protein level. TMA is the latest advancement in the field of pathology. Different sorts of tumors at different phases of disease progression can also be studied at a single stage, in identical conditions in less labor-intensive and cost-effective ways.
View Reports Sample @ https://www.marketresearchfuture.com/sample_request/1213
The market for tissue microarray treatment is growing extensively. It is a practical and efficient tool for high-throughput molecular analysis of tissues that help to identify new diagnostic and prognostic markers. It also targets human cancers and has a range of potential applications in basic research, prognostic oncology, and drug discovery. The growing need for targeted treatments for various chronic diseases such as cancer, genetic diseases, and others has boosted the growth of the market
Increasing application in drug discovery is one of the major factors driving the market growth. During drug research and development, the risk of product failure is high. Moreover, advancement in molecular methods have massively simplified the discovery of potential molecular targets for gene-specific therapy. Application in drug discovery has generated a massive demand for such supposed targets and to meet such demand human tissue analysis is needed. Nevertheless, the need for analysis of large numbers of well-characterized human tissues constitutes a major role in the drug discovery and development. Earlier, tissue analysis used to be done in slide-by-slide manner, which was time consuming, expensive, and difficult to operate.
Increasing prevalence of cancer is one of the important factors that drives the growth of the tissue microarray market. According to the American Cancer Society, in 2017, about 1 in 8 the U.S. women (about 12%) predicted to develop invasive breast cancer over the course of her lifetime. In 2017, an estimated 252,710 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 63,410 new cases of non-invasive (in situ) breast cancer.
However, tissue microarray may not be fruitful for heterogeneous cancers, which may hamper the market growth over the review period.
The global tissue microarray market is expected to grow at a CAGR of 10.88% during the forecast period 2017-2023.
The global tissue microarray market is segmented on the basis of procedure, technology, application, and end user.
On the basis procedure, it is segmented into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array.
On the basis of technology, it is segmented into DNA microarray, polymerase chain reaction, next-generation sequencing, northern blotting, and western blotting.
On the basis of application, it is segmented into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, and comparative genomic hybridization, and sequencing bioinformatics.
On the basis of end user, it is segmented into pharmaceutical and biotechnological companies, research organization, and others.
The Americas dominates the global tissue microarray market owing to the presence of strong economic condition, huge development in healthcare domain, and focus of research institutions on updating technology for new and advanced diagnosis and treatment methods. Moreover, advanced hospitals infrastructures, availability of skilled healthcare professional are boosting the growth of the market.
Europe holds the second position in the market on the basis of increasing emphasis on rapid diagnosis and treatment of cancer, and infectious diseases, changing lifestyle, increasing prevalence of cancer among geriatric population. As per Organization for Economic Co-operation and Development (OECD), the share of GDP to health spending in Germany was 11.0% in 2013, which was 10.8% in 2012, thus this factor also drives the growth of the market in this region. All these factors will drive the market growth in Europe.
Asia Pacific is the fastest growing market owing to more number of developing nations present in this region, for instance, countries like India and china are encouraging the growth of the healthcare domain. Furthermore, increasing patient population from cancer in developing countries will directly increase the demand for various diagnosis & treatment methods and it will boost the growth of the market.
The Middle East & Africa is expected to hold the least market share due to less availability of medical facilities, and less development in the healthcare domain. However, countries such as Qatar and Kuwait are focusing more in healthcare domain and developing medical facilities, which will boost the market growth in this region.
Top 5 Reasons to Get this Report:
Company profiling with detailed strategies, financials, and recent development activities
Market Strategic Business Influence Data
Market Research Future recommendations in key business segments based on the market estimations
Market share analysis of the top industry players
Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis
TABLE OF CONTENTS
1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.1 Introduction 18
2.2 Scope Of Study 18
2.3 Research Objective 18
2.4 Assumptions & Limitations 19
2.4.1 Assumptions 19
2.4.2 Limitations 19
2.5 Market Structure 20
3 RESEARCH METHODOLOGY
3.1 Research Process 21
3.2 Market Size Estimation 23
3.2.1 Market Share Analysis 23
3.3 Forecast Model 25
4 MARKET DYNAMICS
4.1 Drivers 26
4.1.1 Increasing Application In Drug Discovery 26
4.1.2 Increasing Prevalence Of Cancer 26
4.1.3 Increasing Advancements In Biotechnology And Pharmaceutical Companies 27
4.1.4 Increasing Demand For Cost-Effective And Accurate Diagnostic Methods 28
Request Full Report @ https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213
Some of the key players in this market are Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, Qiagen, Takara Bio, Perkin Elmer, Merck Sharp & Dohme Corp, and general electric.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar